ALAR PHARMACEUTICALS INC.

Highlights Alar Pharmaceuticals Inc.

Equities

6785

TW0006785009

End-of-day quote Taipei Exchange Other stock markets 03:30:00 12/06/2024 am IST			5-day change	1st Jan Change
254 ^TWD	-0.59%		-6.27%	+21.24%

10/05	Alar Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
14/03	Alar Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alar Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05	CI
Alar Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03	CI
Alar Pharmaceuticals Inc. Has Received Notice of Allowance for Patent in Taiwan	07/03	CI
Alar Pharmaceuticals Inc. Approves Dividend Distribution for the Year Ended December 31, 2023, Payable on June 28, 2024	06/03	CI
Alar Pharmaceuticals Inc. Receives Notice of Allowance for the Patent Ketamine Pamoate and Use Thereof from United States Patent and Trademark Office	22/02	CI
Alar Pharmaceuticals Inc. Receives Notice of Allowance for the Patent Ketamine Pamoate and Use Thereof from Japan Patent Office	22/02	CI
Alar Pharmaceuticals Inc. Receives Notice of Allowance for the Patent Ketamine Pamoate and Use Thereof from Instituto Mexicano De La Propiedad Industrial	19/02	CI
Alar Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11	CI
Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals	12/23/12	CI
Alar Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/23/10	CI
Alar Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Alar Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	03/23/03	CI
Alar Pharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	11/22/11	CI
Alar Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	24/22/24	CI
Alar Pharmaceuticals Inc. Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000	12/22/12	CI
Alar Pharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2021	14/21/14	CI
Alar Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	26/21/26	CI
Alar Presents Positive Interim Results of Long-Acting Buprenorphine Injectable in Opioid Dependent Patients	09/21/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer